help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 6, 2007
Endocrinology, doi:10.1210/en.2007-0652
A more recent version of this article appeared on December 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/12/5680    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernandez, A.
Right arrow Articles by St. Germain, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernandez, A.
Right arrow Articles by St. Germain, D. L.

Submitted on May 16, 2007
Accepted on August 27, 2007

Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis

Arturo Hernandez*, M. Elena Martinez, Xiao-Hui Liao, Jacqueline Van Sande, Samuel Refetoff, Valerie Anne Galton, and Donald L. St. Germain

Departments of Medicine and, Physiology, Dartmouth Medical School, Lebanon, New Hampshire, USA; Department of Medicine, Pediatrics and the Committees on Genetics and Molecular Medicine, The University of Chicago, Chicago, Illinois, USA; Institute de Recherche Interdisciplinaire, Faculte de Medicine, Universite Libre de Bruxelles, Bruxelles, Belgium

* To whom correspondence should be addressed. E-mail: Arturo.Hernandez{at}Dartmouth.edu.

The type 3 deiodinase (D3) is a selenoenzyme that inactivates thyroid hormones and is highly expressed during development and in the adult central nervous system. We have recently observed that mice lacking D3 activity (D3KO mice) develop perinatal thyrotoxicosis followed in adulthood by a pattern of hormonal levels that is suggestive of central hypothyroidism. In this report we describe the results of additional studies designed to investigate the regulation of the thyroid axis in this unique animal model. Our results demonstrate that the thyroid and pituitary glands of D3KO mice do not respond appropriately to TSH and TRH stimulation, respectively. Furthermore, after induction of severe hypothyroidism by antithyroid treatment, the rise in serum TSH in D3KO mice is only 15% of that observed in wild type (WT) mice. In addition, D3KO animals rendered severely hypothyroid fail to show the expected increase in preproTRH mRNA in the paraventricular nucleus of the hypothalamus. Finally, treatment with T3 results in a serum T3 level in D3KO mice that is much higher than that in WT mice. This is accompanied by significant weight loss and lethality in mutant animals. In conclusion, the absence of D3 activity results in impaired clearance of T3 and significant defects in the mechanisms regulating the thyroid axis at all levels: hypothalamus, pituitary and thyroid.


Key words: type 3 deiodinase • thyroid axis • TRH • TSH • hypothalamus • pituitary







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society